Mitigation of Multi-Organ Radiation Injury with ACE2 Agonist Diminazene Aceturate.

Gasperetti, Tracy; Sharma, Guru Prasad; Frei, Anne C; Pierce, Lauren; Veley, Dana; Szalewski, Nathan; Narayanan, Jayashree; Fish, Brian L; Himburg, Heather A

Gasperetti, Tracy; Sharma, Guru Prasad; Frei, Anne C; Pierce, Lauren; Veley, Dana; Szalewski, Nathan; Narayanan, Jayashree; Fish, Brian L; Himburg, Heather A.

Afiliação

Gasperetti T; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Sharma GP; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Frei AC; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Pierce L; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Veley D; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Szalewski N; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Narayanan J; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Fish BL; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Himburg HA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Radiat Res ; 198(4): 325-335, 2022 10 01.

Article em En | MEDLINE | ID: mdl-35904437

Assuntos

Peptidil Dipeptidase A; Lesões por Radiação; Enzima de Conversão de Angiotensina 2; Animais; Diminazena/análogos & derivados; Peptidil Dipeptidase A/metabolismo; Ratos; Fator de Crescimento Transformador beta

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Lesões por Radiação / Peptidil Dipeptidase A Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Radiat Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google